Literature DB >> 26755870

Naturally derived anti-hepatitis B virus agents and their mechanism of action.

Yi-Hang Wu1.   

Abstract

Despite that some approved drugs and genetically engineered vaccines against hepatitis B virus (HBV) are available for HBV patients, HBV infection is still a severe public health problem in the world. All the approved therapeutic drugs (including interferon-alpha and nucleoside analogues) have their limitations. No drugs or therapeutic methods can cure hepatitis B so far. Therefore, it is urgently needed to discover and develop new anti-HBV drugs, especially non-nucleoside agents. Naturally originated compounds with enormous molecular complexity and diversity offer a great opportunity to find novel anti-HBV lead compounds with specific antiviral mechanisms. In this review, the natural products against HBV are discussed according to their chemical classes such as terpenes, lignans, phenolic acids, polyphenols, lactones, alkaloids and flavonoids. Furthermore, novel mode of action or new targets of some representative anti-HBV natural products are also discussed. The aim of this review is to report new discoveries and updates pertaining to anti-HBV natural products in the last 20 years, especially novel skeletons and mode of action. Although many natural products with various skeletons have been reported to exhibit potent anti-HBV effects to date, scarcely any of them are found in the list of conventional anti-HBV drugs worldwide. Additionly, in anti-HBV mechanism of action, only a few references reported new targets or novel mode of action of anti-HBV natural products.

Entities:  

Keywords:  Drug target; Hepatitis B virus; Mechanism of action; Natural product; Structure

Mesh:

Substances:

Year:  2016        PMID: 26755870      PMCID: PMC4698485          DOI: 10.3748/wjg.v22.i1.188

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  66 in total

1.  A flavonoid from medicinal plants blocks hepatitis B virus-e antigen secretion in HBV-infected hepatocytes.

Authors:  Min Soo Shin; Eun Hwa Kang; Young Ik Lee
Journal:  Antiviral Res       Date:  2005-09       Impact factor: 5.970

2.  Lignan, phenolic and iridoid glycosides from Stereospermum cylindricum.

Authors:  Tripetch Kanchanapoom; Pawadee Noiarsa; Hideaki Otsuka; Somsak Ruchirawat
Journal:  Phytochemistry       Date:  2005-11-28       Impact factor: 4.072

3.  Anti-hepatitis B virus active lactones from the traditional Chinese herb: Swertia mileensis.

Authors:  Chang-An Geng; Li-Jun Wang; Xue-Mei Zhang; Yun-Bao Ma; Xiao-Yan Huang; Jie Luo; Rui-Hua Guo; Jun Zhou; Yong Shen; Ai-Xue Zuo; Zhi-Yong Jiang; Ji-Jun Chen
Journal:  Chemistry       Date:  2011-03-01       Impact factor: 5.236

4.  Polyacetylenes and anti-hepatitis B virus active constituents from Artemisia capillaris.

Authors:  Yong Zhao; Chang-An Geng; Chang-Li Sun; Yun-Bao Ma; Xiao-Yan Huang; Tuan-Wu Cao; Kang He; Hao Wang; Xue-Mei Zhang; Ji-Jun Chen
Journal:  Fitoterapia       Date:  2014-03-29       Impact factor: 2.882

5.  Green tea polyphenol, epigallocatechin-3-gallate, possesses the antiviral activity necessary to fight against the hepatitis B virus replication in vitro.

Authors:  Jing-yao Pang; Kui-jun Zhao; Jia-bo Wang; Zhi-jie Ma; Xiao-he Xiao
Journal:  J Zhejiang Univ Sci B       Date:  2014-06       Impact factor: 3.066

6.  Chemical constituents of Swertia yunnanensis and their anti-hepatitis B virus activity.

Authors:  Tuan-Wu Cao; Chang-An Geng; Fu-Qiang Jiang; Yun-Bao Ma; Kang He; Ning-Jia Zhou; Xue-Mei Zhang; Jun Zhou; Ji-Jun Chen
Journal:  Fitoterapia       Date:  2013-06-05       Impact factor: 2.882

7.  Protocatechuic aldehyde inhibits hepatitis B virus replication both in vitro and in vivo.

Authors:  Zhe Zhou; Yi Zhang; Xiao-Ran Ding; Su-Hong Chen; Jing Yang; Xue-Jun Wang; Gao-Long Jia; Hong-Shan Chen; Xiao-Chen Bo; Sheng-Qi Wang
Journal:  Antiviral Res       Date:  2007-01-16       Impact factor: 5.970

8.  Two new quaternary alkaloids and anti-hepatitis B virus active constituents from Corydalis saxicola.

Authors:  Ying-Rui Wu; Yun-Bao Ma; You-Xing Zhao; Shu-Ying Yao; Jun Zhou; Ying Zhou; Ji-Jun Chen
Journal:  Planta Med       Date:  2007-07-05       Impact factor: 3.352

9.  Synthesis, structure-activity relationships and biological evaluation of dehydroandrographolide and andrographolide derivatives as novel anti-hepatitis B virus agents.

Authors:  Hao Chen; Yun-Bao Ma; Xiao-Yan Huang; Chang-An Geng; Yong Zhao; Li-Jun Wang; Rui-Hua Guo; Wen-Juan Liang; Xue-Mei Zhang; Ji-Jun Chen
Journal:  Bioorg Med Chem Lett       Date:  2014-03-28       Impact factor: 2.823

10.  Astataricusones A-D and astataricusol A, five new anti-HBV shionane-type triterpenes from Aster tataricus L. f.

Authors:  Wen-Bing Zhou; Guang-Zhi Zeng; Hui-Min Xu; Wen-Jun He; Ning-Hua Tan
Journal:  Molecules       Date:  2013-11-25       Impact factor: 4.411

View more
  12 in total

1.  Alisol B 23-Acetate Increases the Antitumor Effect of Bufalin on Liver Cancer through Inactivating Wnt/β-Catenin Axis.

Authors:  Miaoqing Ye; Yinghui Tang; Jinyu He; Xueyan Cao; Jiaojiao Liu; Shaojie Kou; Yueqing Yang; Jingdong Xue; Fenping Li
Journal:  Comput Math Methods Med       Date:  2022-05-06       Impact factor: 2.809

2.  (-)-Lariciresinol Isolated from the Roots of Isatis indigotica Fortune ex Lindl. Inhibits Hepatitis B Virus by Regulating Viral Transcription.

Authors:  Lu Yang; Huiqiang Wang; Haiyan Yan; Kun Wang; Shuo Wu; Yuhuan Li
Journal:  Molecules       Date:  2022-05-18       Impact factor: 4.927

3.  Antiviral Activity of Cananga odorata Against Hepatitis B Virus.

Authors:  Puguh Indrasetiawan; Chie Aoki-Utsubo; Muhammad Hanafi; Sri Hartati; Tutik Sri Wahyuni; Masanori Kameoka; Yoshihiko Yano; Hak Hotta; Yoshitake Hayashi
Journal:  Kobe J Med Sci       Date:  2019-11-12

4.  Bioassay-guided isolation of anti-hepatitis B virus flavonoid myricetin-3-O-rhamnoside along with quercetin from Guiera senegalensis leaves.

Authors:  Mohammad K Parvez; Mohammed S Al-Dosari; Ahmed H Arbab; Adnan J Al-Rehaily; Mazin A S Abdelwahid
Journal:  Saudi Pharm J       Date:  2020-03-19       Impact factor: 4.330

Review 5.  Antiviral Agents in Development for Zika Virus Infections.

Authors:  Mariana Baz; Guy Boivin
Journal:  Pharmaceuticals (Basel)       Date:  2019-06-29

Review 6.  Medicinal plants: Treasure for antiviral drug discovery.

Authors:  Sofi Imtiyaz Ali; Wajid Mohammad Sheikh; Muzafar Ahmad Rather; Venugopalan Venkatesalu; Showkeen Muzamil Bashir; Showkat Ul Nabi
Journal:  Phytother Res       Date:  2021-02-16       Impact factor: 6.388

Review 7.  Antibiotic resistance modifying ability of phytoextracts in anthrax biological agent Bacillus anthracis and emerging superbugs: a review of synergistic mechanisms.

Authors:  Mackingsley Kushan Dassanayake; Teng-Jin Khoo; Jia An
Journal:  Ann Clin Microbiol Antimicrob       Date:  2021-12-02       Impact factor: 3.944

8.  In vitro evaluation of novel antiviral activities of 60 medicinal plants extracts against hepatitis B virus.

Authors:  Ahmed Hassan Arbab; Mohammad Khalid Parvez; Mohammed Salem Al-Dosari; Adnan Jathlan Al-Rehaily
Journal:  Exp Ther Med       Date:  2017-05-31       Impact factor: 2.447

Review 9.  The A-Z of Zika drug discovery.

Authors:  Melina Mottin; Joyce V V B Borba; Rodolpho C Braga; Pedro H M Torres; Matheus C Martini; Jose Luiz Proenca-Modena; Carla C Judice; Fabio T M Costa; Sean Ekins; Alexander L Perryman; Carolina Horta Andrade
Journal:  Drug Discov Today       Date:  2018-06-20       Impact factor: 7.851

Review 10.  Current landscape and future prospects of antiviral drugs derived from microbial products.

Authors:  Naoki Takizawa; Manabu Yamasaki
Journal:  J Antibiot (Tokyo)       Date:  2017-10-11       Impact factor: 2.649

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.